Celyad Oncology (CYAD) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free CYAD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 4, 2024 | finance.yahoo.comCelyad Oncology Reports Full Year 2023 Financial Results and Recent Business HighlightsMarch 29, 2024 | seekingalpha.comCSBR Champions Oncology, Inc.January 17, 2024 | finanznachrichten.deCelyad Oncology SA: Celyad Oncology provides fourth quarter 2023 business update and 2024 outlookJanuary 16, 2024 | finance.yahoo.comCelyad Oncology provides fourth quarter 2023 business update and 2024 outlookDecember 17, 2023 | businesswire.comCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)December 4, 2023 | finance.yahoo.comCelyad Announces Management ChangeNovember 14, 2023 | tmcnet.comInformation on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 MayNovember 11, 2023 | lse.co.ukCelyad Oncology Share Price (CYAD.BR)November 9, 2023 | finanznachrichten.deCelyad Oncology SA: Celyad Oncology reports third quarter 2023 financial results and recent business highlightsNovember 9, 2023 | finance.yahoo.comCelyad Oncology reports third quarter 2023 financial results and recent business highlightsSeptember 26, 2023 | finanznachrichten.deCelyad Oncology SA: Celyad Oncology announces the termination of its American Depository Receipt programSeptember 25, 2023 | marketwatch.comCelyad Oncology to Terminate ADR ProgramSeptember 25, 2023 | finance.yahoo.comCelyad Oncology announces the termination of its American Depository Receipt programSeptember 15, 2023 | finance.yahoo.comCelyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLCSeptember 12, 2023 | businesswire.comCelyad Oncology SA: Publication of a Transparency Notification Received from Tolefi SASeptember 12, 2023 | ca.finance.yahoo.comCelyad Oncology SA (CYAD.BR)September 7, 2023 | finance.yahoo.comCelyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLCSeptember 4, 2023 | finanznachrichten.deCelyad Oncology SA: Celyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsSeptember 4, 2023 | finance.yahoo.comCelyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsSeptember 4, 2023 | investing.comCelyad Oncology (CYADY) Earnings Dates & ReportsAugust 29, 2023 | finance.yahoo.comCelyad Oncology Receives Approximately EUR 9.8m in Private Placement Commitments From Historical ShareholdersAugust 25, 2023 | finanznachrichten.deCelyad Oncology SA: Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholdersJuly 19, 2023 | investing.comCelyad Oncology SA (CYADY)May 16, 2023 | finanznachrichten.deCelyad Oncology SA: Celyad Oncology announces receipt of Nasdaq delisting noticeMay 15, 2023 | finance.yahoo.comCelyad Oncology Announces Receipt of Nasdaq Delisting NoticeMay 5, 2023 | msn.comCelyad plans to delist from Nasdaq amid cash woesMay 5, 2023 | finance.yahoo.comCelyad Oncology reports first quarter 2023 financial results and recent business highlightsMay 5, 2023 | finance.yahoo.comCelyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From NasdaqApril 27, 2023 | finanznachrichten.deCelyad Oncology SA: Celyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid PriceApril 24, 2023 | finance.yahoo.comCelyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid PriceApril 4, 2023 | finance.yahoo.comCelyad Oncology announces receipt of Nasdaq noticeMarch 27, 2023 | finance.yahoo.comCelyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call TranscriptMarch 24, 2023 | markets.businessinsider.comCelyad Oncology Appoints Georges Rawadi As CEO - Quick FactsMarch 24, 2023 | finance.yahoo.comCelyad Oncology Appoints Georges Rawadi as Its New CEOMarch 23, 2023 | finanznachrichten.deCelyad Oncology SA: Celyad Oncology Reports Full Year 2022 Financial Results and Recent Business HighlightsMarch 23, 2023 | finance.yahoo.comCelyad Oncology reports full year 2022 financial results and recent business highlightsMarch 17, 2023 | finance.yahoo.comCelyad Oncology to Announce Full Year 2022 Financial Results and Host Conference CallMarch 15, 2023 | msn.comCelyad slumps ~30% as board to put proposal to continue activities on vote at shareholders' meetMarch 15, 2023 | finance.yahoo.comCelyad Oncology announces non-cash impairmentMarch 1, 2023 | finance.yahoo.comCelyad Oncology: Letter to ShareholdersMarch 1, 2023 | finance.yahoo.comREPEAT -- Celyad Oncology SA - Letter to ShareholdersFebruary 28, 2023 | finance.yahoo.comCelyad Oncology SA - Letter to ShareholdersFebruary 9, 2023 | finance.yahoo.comCelyad Oncology Announces the Publication of Data From Its Phase 1 THINK Study of CYAD-01February 3, 2023 | uk.finance.yahoo.comCelyad Oncology provides fourth quarter 2022 business update and 2023 outlookJanuary 18, 2023 | ca.finance.yahoo.comCelyad Oncology SA (CYAD)January 17, 2023 | benzinga.comThinking about buying stock in Celyad Oncology, Calyxt, IQIYI, Vinco Ventures, or Carvana?January 17, 2023 | marketbeat.comTrading was temporarily halted for "CYAD" at 09:01 AM with a stated reason of "LULD pause."December 29, 2022 | finance.yahoo.comCelyad Oncology Completely Shifts To Preclinical Stage, Pulls Plug On Only Human Trial AssetDecember 21, 2022 | tmcnet.comCelyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harnessDecember 21, 2022 | markets.businessinsider.comCelyad Oncology To Discontinue CYAD-211 Clinical Program In Multiple Myeloma Get Celyad Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAD and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry CYAD Media Mentions By Week CYAD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYAD News Sentiment▼0.000.42▲Average Medical News Sentiment CYAD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYAD Articles This Week▼00▲CYAD Articles Average Week Get Celyad Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vincerx Pharma News Flora Growth News NeuroSense Therapeutics News Tonix Pharmaceuticals News Talphera News Minerva Neurosciences News Edesa Biotech News GlycoMimetics News FSD Pharma News Pieris Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYAD) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsUrgent Nvidia WarningAltimetryDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celyad Oncology SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
